{"id":432878,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2017-03-29] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T09:05:29.628000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-prescription-drug-list-multiple-additions.html?wbdisable=true","snippet":"Notice - Prescription Drug List (PDL): Multiple additions March 29, 2017 Our file number: 17-103107-174 The purpose of this Notice of Amendment is to notify the additions of Eluxadoline, Peramivir, Propiverine hydrochloride and Sarilumab to the Human and Veterinary Prescription…","rawSnapshotUrl":"/api/snapshots/raw/432878","browseUrl":"https://replay.healtharchive.ca/job-6/20260102090529/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-prescription-drug-list-multiple-additions.html?wbdisable=true#ha_snapshot=432878","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}